Domestic markets are likely to open on flat note despite fresh tariff threats from the us president on pharmaceutical drugs. Gift nifty is ruling at 25,030 against the nifty September futures value of 24,967.70 and October futures value of 25,093.70. Analysts Expect the Weak Trend to Continue Amid Heavy Selling from Foreign Portfolio Investors

Ponmudi R, CEO of Enrich Money, Said, Gift Nifty Indicates a Flat to Mildly Negative Start for Indian Equites Today, Reflecting a Cauthous Mood Account. Investor Attention will squarely be on the domestic pharma sector after the Trump Administration Announced A 100% Tariff on Imports of Branded or PHARNED PHARANDED PHARMACEUTICAL DRECTICAL DRECETICAL Products Effects Effects Effects Effects Effect Move poses a direct risk to over $ 3.6 billion of annual Indian Pharma Exports to the Us, Raising Concerns for Companies with Significant Us Exposure, “He Said.

Analysts Expect the Benchmark Indices to Move in a Narrow Range, Thought select counters such as pharma and it will remain under pressure.

This tariff action comes close on the heels of the steep hike in us h-1b visa fees, which has alredy triggered heavy seling in the it sector stocks over the past sector stocks over the past sector. The ripple effect has also been attained in the forex market, where the sustained outflows and risk averse have dragged the rupee to a record low, further amplifying investor cONCERNS, PONMI FURURTH SAIDD.

Amruta Shinde, Technical & Derivative Analyst at Choice Equity Broking Private Ltd, Said: With Foreign Selling Showing No Abtement and Us Visa Policy Headwinds Dragging, ESPECIALYLY ONT and Export-oriented Names, Markets May Remain Choppy in Near Term. “

Meanwhile, global stocks are also sending bearish signals. Most equities across the asia-pacific region are in the red in the early morning trade on Friday.

Published on September 26, 2025